Related Experiment Video
Updated: Jan 30, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Two-year evolution of latent rheumatic heart disease in Malawi
Amy Sanyahumbi1, Andrea Beaton2, Danielle Guffey3
1Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
Insights
Rheumatic heart disease (RHD) screening in children showed low progression rates. Borderline RHD cases rarely advanced to definite RHD, indicating a favorable prognosis in this group.
Area of Science:
- Cardiology
- Pediatrics
- Public Health
Background:
- Screening echocardiography is used to detect latent rheumatic heart disease (RHD) in asymptomatic children.
- World Heart Federation guidelines categorize RHD as definite, borderline, or absent based on echocardiogram findings.
- The natural progression of RHD diagnosed via screening is largely unknown.
Purpose of the Study:
- To evaluate the 2-year evolution of rheumatic heart disease (RHD) in children initially diagnosed through screening echocardiography.
- To assess progression and regression rates in both definite and borderline RHD cases.
Main Methods:
- Follow-up echocardiograms were performed after two years on children diagnosed with latent RHD.
- Echocardiogram readings involved a multi-reader approach to ensure accuracy.
- Factors such as penicillin adherence, age, gender, and socioeconomic status were compared between RHD progression groups.
Main Results:
- Among 39 borderline RHD cases, only 2.6% progressed to definite RHD; 43.6% regressed to normal.
- Of 11 definite RHD cases, 36.4% regressed to borderline, and 9.1% regressed to normal.
- No significant differences in adherence or demographic factors were found between those who regressed and those who did not.
Conclusions:
- Children diagnosed with borderline rheumatic heart disease (RHD) exhibit a low rate of progression to definite RHD.
- The study achieved a high participant retention rate of 98%.
- Further long-term follow-up is necessary to fully understand the expected disease trajectory of RHD detected through screening.
Background:
In asymptomatic children, screening echocardiography has been used to attempt to diagnose rheumatic heart disease (RHD) at an early stage (latent RHD). World Heart Federation guidelines have standardized categorization of "definite," "borderline," or no RHD by echo findings. The progression of RHD diagnosed through echo screening is not known. In 2014, we screened 1450 schoolchildren in Malawi.
Objective:
Our objective was to evaluate 2-year RHD evolution among those diagnosed through screening.
Methods:
Two-year follow-up echocardiograms of those diagnosed with latent RHD were read by a primary, secondary, then third reader if there was disagreement. Progression or regression of both definite and borderline groups were tabulated. Penicillin adherence, age, gender, number in home, and household income were compared between those with definite RHD who regressed to borderline and those that stayed definite. We utilized the local system used to track HIV defaulters in order to bring participants back into care. Comparisons were made using Fisher's exact and Wilcoxon rank-sum tests.
Results:
Of the 39 with borderline RHD, 1 was lost to follow-up (2.6%), 1 progressed to definite (2.6%), 19 remained borderline (48.7%), 17 (43.6%) regressed to normal, and 1 was reclassified as mitral valve prolapse (2.6%). Of the 11 with definite RHD, 6 (54.5%) remained definite, 4 regressed to borderline (36.4%), and 1 regressed to normal (9.1%). Two of 11 with definite RHD had penicillin adherence above 80% for the 2-year follow-up period. There were no differences in adherence, gender, age, household income, or number in household between those with definite RHD that regressed to borderline and those who did not (P > .19).
Conclusions:
Borderlines had a very low progression rate to definite RHD. A strength of our study was a high retention rate (98%). Longer follow-up is needed to determine expected disease evolution.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The Evidence for Evolution
Convergent Evolution

